FDA Investigator Brian R Yuan
Brian R Yuan has inspections in 1 countries as of 04 Nov 2022. Brian R Yuan has collaborated with a combined 757 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
4
Last Inspection Date:
04 Nov 2022
Investigator Role:
FDA Investigation Participant
Redica ID:
Country:
United States of America
Co-Investigator(s):
Asamoah Asamoah,
Brian L Belz,
Brian R Yaun,
Brooke K Higgins,
Brooke K Seeman,
Burnell M Henry,
Carl A Huffman, III,
Carrie L Doupnik,
Carter,
Christopher J Adams,
David R Heiar,
Dennis L Doupnik,
Douglas A Campbell,
Dr. Gang Wang, PhD,
Eileen A Liu,
Emest F Bizjak,
Eric L Dong, BS,
Fabian Chaparro,
Fabian Nchaparro Rodriguez,
George Pyramides,
Gifford Whitehurst, Jr,
Jacqueline S Warner,
Jonathan W Chapman,
Justin N Henson,
Lawrence Harmon, Jr,
LCDR Debra Emerson,
Marcus A Ray,
Markeesa M Scales,
Melissa J Garcia,
Qin Xu,
Sam Pepe,
Sandy L Atkins,
Scott A Watson,
Simone E Pitts,
State Agency,
Susan M Jackson,
Thomas O Morgan,
Thomas R Stanley,
Thomas R Withers,
Tony E Bable,
Toyin B Oladimeji,
Vesna V Stanoyevitch,
William P Tonkins,
Zhongren Wu
Brian R Yuan's Documents
Publish Date | Document Type | Title |
---|---|---|
April, 2004 | FDA 483 | Barr Laboratories, Inc. (div. Of Teva) - Form 483, 2004-04-14 |
February, 2011 | EIR | Centra Health Inc IRB - EIR, 2011-02-15 |
February, 2011 | FDA 483 | Centra Health Inc IRB - Form 483, 2011-02-15 |
April, 2017 | FDA 483 | Conagra Brands, Inc. - Form 483, 2017-04-27 |
March, 2008 | EIR | Barr Laboratories Inc. - EIR, 2008-03-24 |
February, 2011 | FDA 483 Response | Centra Health Inc IRB - Form 483R, 2011-03-02 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more